Clinical trials
Recruiting Phase 3 trials in Peru
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
56 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2022 | 2 |
| 2023 | 13 |
| 2024 | 17 |
| 2025 | 18 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 56 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 21 |
| AstraZeneca | 17 |
| Amgen | 2 |
| Karuna Therapeutics, Inc., a Bristol Myers Squibb company | 2 |
| Anthos Therapeutics, Inc. | 1 |
| Bristol-Myers Squibb | 1 |
| Colorado Prevention Center | 1 |
| Ipsen | 1 |
| NRG Oncology | 1 |
| Octapharma | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 10 |
| Breast Neoplasms | 5 |
| Heart Failure | 3 |
| Lung Neoplasms | 3 |
| Prostatic Neoplasms | 3 |
| Renal Insufficiency, Chronic | 3 |
| COVID-19 | 2 |
| Fallopian Tube Neoplasms | 2 |
| Ovarian Neoplasms | 2 |
| Pulmonary Disease, Chronic Obstructive | 2 |
Trials
Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.